FB dot image

Women’s Health Nurse Practitioner (WHNP) Module Overview

Continuing Education Review/Clinical Update Course

  • This program has been approved for 21.5 contact hours of continuing education (which includes 9.5 hours of pharmacology)
  • Extensive course manual

Course Overview

Test-taking and Study Strategies for Success
Physical Assessment and Diagnostic Evaluation

  • Health History
  • Physical Exam

Laboratory/Diagnostic Studies and Procedures

  • Hematological studies
    • CBC and WBC indices, blood typing, antibody screening, coagulation profiles, hemoglobin A1C
  • Serologic studies
  • Hormone studies, LFTs, HIV testing, antibody detection, other infectious diseases
  • Kidney function
  • Body fluids
    • U/A, fecal testing, vaginal smears, cervical and vaginal cultures, cervical cytology, GBS cultures, tests for ruptured membranes
  • BUN, creatinine, creatinine clearance
  • Lipid profiles
  • Endoscopic procedures
    • Colposcopy, diagnostic laparoscopy, hysteroscopy, colonoscopy/sigmoidoscopy
  • Imaging studies
    • X-rays, ultrasound, mammography, bone densitometry
  • Biopsies
    • Endometrial, cervix, vulva, breast
  • Genetics
    • Markers, karyotyping, gene identification

Primary Care Extensive Review of System-Specific Health Problems

  • Skin
  • Pulmonary
  • Cardiovascular
  • Gastrointestinal
  • Genitourinary
  • Musculoskeletal
  • Neurological/psychiatric
  • Endocrine
  • Hematologic
  • Immunologic

Health Promotion and Patient Counseling

  • Risk assessments
  • Disease prevention
  • National screening guidelines
  • Health promotion advice
  • Dysfunctional social patterns
  • Preconception counseling

Gynecologic Disorders

  • Assessment, diagnosis, treatment, referral, counseling, education
    • Abnormalities of puberty, menstrual disorders, vaginitis/vaginosis, STIs, UTIs, pelvic pain, infertility
  • Cervical cytology and HPV testing
  • Benign uterine/cervical conditions
  • Adenomyosis, adnexal masses, cervical and endometrial polyps, leiomyomata uteri
  • Malignant disorders (endometrium, cervix, ovary, vagina/vulva)
  • Breast disorders (cancer, fibroadenoma, fibrocystic breast changes)
  • Climacteric/post-menopause
  • Pelvic organ relaxation and prolapse
  • Polycystic ovarian syndrome
  • Vulvar dystrophies and dermatoses
  • Reproductive health care
  • Pregnancy prevention
    • Cycle timing, barrier methods, pharmacologic methods – oral, injection, implants, transdermal, vaginal, intrauterine contraception, tubal occlusion methods
  • Unintended pregnancy
    • Induced abortion, adoption, options counseling
  • Men’s issues affecting women’s health
    • Sexuality/sexual dysfunction, contraception, infertility, STIs


  • Physiology of pregnancy
    • Normal fetal-placental development, alterations in maternal anatomy and physiology, emotional and behavioral changes
  • Prenatal care
    • Gestational dating, risk assessment, nutrition, immunologic status, medication assessment, health guidance, screening tests, common discomforts of pregnancy, pregnancy specific examination
  • Fetal assessment
    • Amniocentesis, amniotic fluid index, biophysical profile, chorionic villus sampling, contraction stress testing, fetal movement counting, genetic screening, maternal serum markers, nonstress testing, tests for fetal lung maturity, ultrasound
    • Complications of pregnancy
      • Maternal medical disorders
        • Metabolic, infectious, cardiovascular, renal, gastrointestinal, respiratory, hematologic, substance abuse
      • Placental abnormalities
        • Trophoblastic disease, placenta previa, abruptio placenta, amniotic fluid volume
      • Pregnancy specific conditions: Spontaneous abortion, incompetent cervix, intrauterine fetal death, multiple gestation, prematurity, postmaturity, ectopic pregnancy, preterm labor, hyperemesis gravidarum, gestational hypertension, malpresentations, Rh isoimmunization, coping with pregnancy loss


  • Physiologic changes
    • CV, endocrine, GI, hematological, respiratory, renal/urinary, uterine/pelvic changes/involution
  • General care issues
    • After pains, care of breasts and perineal area, fatigue, sleep disturbances, issues related to non-breastfeeding mothers, postpartum exercises, contraception
  • Breastfeeding
    • Contraindications, complications – engorgement, infections, nipple soreness, plugged ducts; nutritional needs, physiology of lactation, positioning, and infant feeding
  • Family integration
    • Barriers to parent infant interactions, environmental factors affecting family integration, normal parent-infant interactions, principles of grieving, sibling responses and interventions
  • Complications of the postpartum period
    • Bladder distention, urinary retention, hematoma, hemorrhage, hemorrhoids, postpartum depression/psychosis, reproductive and urinary tract infections, thrombophlebitis


  • Pharmacokinetics/Pharmacodynamics
    • Pharmacokinetic properties of drugs: Absorption, metabolism, elimination excretion
    • Pharmacodynamic properties: Mechanism of action, drug receptor binding, drug interactions, contraindications
    • Pharmacotherapeutics: Prescription and OTC indications, side effects, drug interactions, contraindications, patient education

Professional Issues

  • Evidence-based practice
    • Types of research designs, application of research findings to evidence-based practice, statistical reliability, generalizability of research findings, replication of outcomes, ethical considerations
  • Ethical principles
  • Legal issues
    • Informed consent, protections of information, national mandates
  • Risk management
  • Scope of practice
    Your cart is emptyReturn to Shop